Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001008032 | SCV001167765 | likely pathogenic | not provided | 2019-03-21 | criteria provided, single submitter | clinical testing | A variant that is likely pathogenic has been identified in the NGLY1 gene. The L637X variant has been previously reported in a patient with a clinical diagnosis of NGLY1-CDDG who had a second variant on the opposite allele (Lam et al., 2017; Kong et al., 2017). The L637X variant is not observed in large population cohorts (Lek et al., 2016). L637X is predicted to cause loss of normal protein function through protein truncation as the last 18 amino acids are lost. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |
Medical Biochemical Genetics, |
RCV000496180 | SCV000259185 | pathogenic | Congenital disorder of deglycosylation | 2016-01-07 | no assertion criteria provided | clinical testing |